Markus A. Ruegg
Basel, BS 4056, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Laminin-α2 is required for the maintenance of the myotendinous junction in vivo.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: January 23, 2026
Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 08, 2025
AAV capsids target muscle-resident cells with different efficiencies-A comparative study between AAV8, AAVMYO, and AAVMYO2.
Journal: Molecular therapy. Methods & clinical development
Published: September 21, 2024
Single-nuclei sequencing of skeletal muscle reveals subsynaptic-specific transcripts involved in neuromuscular junction maintenance.
Journal: Nature communications
Published: May 08, 2024
Neural xenografts contribute to long-term recovery in stroke via molecular graft-host crosstalk.
Journal: Nature communications
Published: April 18, 2024
Muscle fiber Myc is dispensable for muscle growth and its forced expression severely perturbs homeostasis.
Journal: Nature communications
Published: March 30, 2024
CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I.
Journal: Skeletal muscle
Published: February 11, 2024
Calorie restriction and rapamycin distinctly restore non-canonical ORF translation in the muscles of aging mice.
Journal: NPJ Regenerative medicine
Published: January 03, 2024
Raptor levels are critical for β-cell adaptation to a high-fat diet in male mice.
Journal: Molecular metabolism
Published: April 20, 2023
Last Updated: 09/26/2026